NAV
₹17.2360
as of 31 Jul 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +20.57%
- 3Y
- —
- 5Y
- —
- Since Inception
- +22.39%
SIP returns (XIRR)
- 1Y
- +38.71%
- 3Y
- —
- 5Y
- —
- Since Inception
- +21.92%
Returns calculated from 20 November 2023 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Performance Comparison
Thinking about Kotak Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Kotak Healthcare Fund - Regular Plan - Growth Option
- 1Sun Pharmaceutical Industries Ltd.13.73%
- 2Max Healthcare Institute Ltd.5.99%
- 3Jb Chemicals & Pharmaceuticals Ltd.5.45%
- 4Divis Laboratories Ltd.5.33%
- 5Ami Organics Ltd5.20%
- 6Cipla Ltd.4.32%
- 7Fortis Healthcare India Ltd4.02%
- 8Park Medi World Limited (Park Hospital)3.97%
- 9Mankind Pharma Ltd3.38%
- 10Yatharth Hospital And Trauma Care Services Ltd3.15%
Investment Objective
Kotak Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Kotak Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Kotak Mahindra Mutual Fund. The fund has been operational for over 2 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations